126 related articles for article (PubMed ID: 37183367)
1. Petite Integration Factor 1 knockdown enhances gemcitabine sensitivity in pancreatic cancer cells via increasing DNA damage.
Wang K; Hua X; Fu X; Hao Z; Jiao A; Li S
J Appl Toxicol; 2023 Oct; 43(10):1522-1532. PubMed ID: 37183367
[TBL] [Abstract][Full Text] [Related]
2. Effects of ribosomal associated protein hnRNP D in gemcitabine-resistant pancreatic cancer.
Wang C; Huang H
Biochem Biophys Res Commun; 2021 Nov; 579():181-187. PubMed ID: 34624736
[TBL] [Abstract][Full Text] [Related]
3. LncRNA SNHG8 promotes the development and chemo-resistance of pancreatic adenocarcinoma.
Song Y; Zou L; Li J; Shen ZP; Cai YL; Wu XD
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8161-8168. PubMed ID: 30556854
[TBL] [Abstract][Full Text] [Related]
4. Modulation of pancreatic cancer chemoresistance by inhibition of TAK1.
Melisi D; Xia Q; Paradiso G; Ling J; Moccia T; Carbone C; Budillon A; Abbruzzese JL; Chiao PJ
J Natl Cancer Inst; 2011 Aug; 103(15):1190-204. PubMed ID: 21743023
[TBL] [Abstract][Full Text] [Related]
5. TM4SF1 Promotes Gemcitabine Resistance of Pancreatic Cancer In Vitro and In Vivo.
Cao J; Yang J; Ramachandran V; Arumugam T; Deng D; Li Z; Xu L; Logsdon CD
PLoS One; 2015; 10(12):e0144969. PubMed ID: 26709920
[TBL] [Abstract][Full Text] [Related]
6. ZIP4 Increases Expression of Transcription Factor ZEB1 to Promote Integrin α3β1 Signaling and Inhibit Expression of the Gemcitabine Transporter ENT1 in Pancreatic Cancer Cells.
Liu M; Zhang Y; Yang J; Cui X; Zhou Z; Zhan H; Ding K; Tian X; Yang Z; Fung KA; Edil BH; Postier RG; Bronze MS; Fernandez-Zapico ME; Stemmler MP; Brabletz T; Li YP; Houchen CW; Li M
Gastroenterology; 2020 Feb; 158(3):679-692.e1. PubMed ID: 31711924
[TBL] [Abstract][Full Text] [Related]
7. PTK6 Potentiates Gemcitabine-Induced Apoptosis by Prolonging S-phase and Enhancing DNA Damage in Pancreatic Cancer.
Ono H; Basson MD; Ito H
Mol Cancer Res; 2015 Aug; 13(8):1174-84. PubMed ID: 26013168
[TBL] [Abstract][Full Text] [Related]
8. TIMP1 down-regulation enhances gemcitabine sensitivity and reverses chemoresistance in pancreatic cancer.
Tan Y; Li X; Tian Z; Chen S; Zou J; Lian G; Chen S; Huang K; Chen Y
Biochem Pharmacol; 2021 Jul; 189():114085. PubMed ID: 32522594
[TBL] [Abstract][Full Text] [Related]
9. EGR1 mediates MDR1 transcriptional activity regulating gemcitabine resistance in pancreatic cancer.
Yang Z; Chen F; Wei D; Chen F; Jiang H; Qin S
BMC Cancer; 2024 Feb; 24(1):268. PubMed ID: 38408959
[TBL] [Abstract][Full Text] [Related]
10. Suppression of STAT5b in pancreatic cancer cells leads to attenuated gemcitabine chemoresistance, adhesion and invasion.
Sumiyoshi H; Matsushita A; Nakamura Y; Matsuda Y; Ishiwata T; Naito Z; Uchida E
Oncol Rep; 2016 Jun; 35(6):3216-26. PubMed ID: 27035235
[TBL] [Abstract][Full Text] [Related]
11. Gemcitabine treatment induces endoplasmic reticular (ER) stress and subsequently upregulates urokinase plasminogen activator (uPA) to block mitochondrial-dependent apoptosis in Panc-1 cancer stem-like cells (CSCs).
Wang L; Zhang Y; Wang W; Zhu Y; Chen Y; Tian B
PLoS One; 2017; 12(8):e0184110. PubMed ID: 28854261
[TBL] [Abstract][Full Text] [Related]
12. Gambogic acid sensitizes gemcitabine efficacy in pancreatic cancer by reducing the expression of ribonucleotide reductase subunit-M2 (RRM2).
Xia G; Wang H; Song Z; Meng Q; Huang X; Huang X
J Exp Clin Cancer Res; 2017 Aug; 36(1):107. PubMed ID: 28797284
[TBL] [Abstract][Full Text] [Related]
13. PMEPA1 interference activates PTEN/PI3K/AKT, thereby inhibiting the proliferation, invasion and migration of pancreatic cancer cells and enhancing the sensitivity to gemcitabine and cisplatin.
Yang Y; Cheng T; Xie P; Wang L; Chen H; Cheng Z; Zhou J
Drug Dev Res; 2022 Feb; 83(1):64-74. PubMed ID: 34189738
[TBL] [Abstract][Full Text] [Related]
14. Knockdown of clusterin sensitizes pancreatic cancer cells to gemcitabine chemotherapy by ERK1/2 inactivation.
Tang Y; Liu F; Zheng C; Sun S; Jiang Y
J Exp Clin Cancer Res; 2012 Sep; 31(1):73. PubMed ID: 22967941
[TBL] [Abstract][Full Text] [Related]
15. Enhancement of gemcitabine sensitivity in pancreatic cancer by co-regulation of dCK and p8 expression.
Tang K; Zhang Z; Bai Z; Ma X; Guo W; Wang Y
Oncol Rep; 2011 Apr; 25(4):963-70. PubMed ID: 21225236
[TBL] [Abstract][Full Text] [Related]
16. Integrin β1 promotes gemcitabine resistance in pancreatic cancer through Cdc42 activation of PI3K p110β signaling.
Yang D; Tang Y; Fu H; Xu J; Hu Z; Zhang Y; Cai Q
Biochem Biophys Res Commun; 2018 Oct; 505(1):215-221. PubMed ID: 30243721
[TBL] [Abstract][Full Text] [Related]
17. [Down-regulation of Notch1 by small interfering RNA enhances chemosensitivity to gemcitabine in pancreatic cancer cells through activating apoptosis activity].
Du X; Wang YH; Wang ZQ; Cheng Z; Li Y; Hu JK; Chen ZX; Zhou ZG
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2014 May; 43(3):313-8. PubMed ID: 24998655
[TBL] [Abstract][Full Text] [Related]
18. Nicotine promotes epithelial to mesenchymal transition and gemcitabine resistance via hENT1/RRM1 signalling in pancreatic cancer and chemosensitizing effects of Embelin-a naturally occurring benzoquinone.
Prashanth N ; Meghana P ; Sandeep Kumar Jain R ; Pooja S Rajaput ; Satyanarayan N D ; Raja Naika H ; Kumaraswamy H M
Sci Total Environ; 2024 Mar; 914():169727. PubMed ID: 38163613
[TBL] [Abstract][Full Text] [Related]
19. Sirtuin 1 facilitates chemoresistance of pancreatic cancer cells by regulating adaptive response to chemotherapy-induced stress.
Zhang JG; Hong DF; Zhang CW; Sun XD; Wang ZF; Shi Y; Liu JW; Shen GL; Zhang YB; Cheng J; Wang CY; Zhao G
Cancer Sci; 2014 Apr; 105(4):445-54. PubMed ID: 24484175
[TBL] [Abstract][Full Text] [Related]
20. Integrinβ1 modulates tumour resistance to gemcitabine and serves as an independent prognostic factor in pancreatic adenocarcinomas.
Yang D; Shi J; Fu H; Wei Z; Xu J; Hu Z; Zhang Y; Yan R; Cai Q
Tumour Biol; 2016 Sep; 37(9):12315-12327. PubMed ID: 27289231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]